Author

Seth Tjia

Nanyang Technological UniversityORCID 0000-0003-1248-6194Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Zbynek BozdechiD· 3 shared Jerzy Michal DziekaniD· 2 shared Peter Rainer PreiseriD· 2 shared Samuel PažickýiD· 2 shared Alexander SchmidtiD· 1 shared Angjing Wen· 1 shared Armin PasseckeriD· 1 shared Basil T. ThommeniD· 1 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Zbynek BozdechORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 3, 2026

Multi-omic profiling of Plasmodium knowlesi blood stages identifies host adaptation barriers

Samuel Pažický, Nicolas Aranciaga, Xiahong Gao…·Zbynek Bozdech

This study identifies host adaptation barriers in Plasmodium knowlesi by analyzing multi-omic data from parasites cultured in human and macaque red blood cells.

DOI 10.64898/2026.10.02.756168

humanmouse

𝕏 PostBluesky

MicrobiologyMolecular & Cellular ProteomicsPeer-reviewedOct 1, 2026

Thermal proteome profiling identifies new drug targets in Plasmodium falciparum parasites

Samuel Pažický, Jerzy Michal Dziekan, Seth Tjia…·Zbynek Bozdech

The paper identifies new drug targets in Plasmodium falciparum using thermal proteome profiling combined with molecular docking and MS-CETSA.

2 citationstop 2%

humanproteomics

𝕏 PostBluesky

Molecular BiologyeLifePeer-reviewedNov 7, 2023

Genetic validation of PfFKBP35 as an antimalarial drug target

Basil T. Thommen, Jerzy Michal Dziekan, Fiona Achcar…·Nicolas M. B. Brancucci

This study genetically validates PfFKBP35 as a lethal target in Plasmodium falciparum, showing its role in ribosome homeostasis and revealing non-canonical modes of action for FK506.

5 citations

humanexperimental assay

𝕏 PostBluesky